VandenBroeke T, Dumont L J, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon J P, Gulliksson H, Dengler T, Hornsey V, Prowse Chris
Gambro BCT, Lakewood, CO, USA.
Vox Sang. 2004 Apr;86(3):183-8. doi: 10.1111/j.0042-9007.2004.00412.x.
Extent of shape change (ESC) and hypotonic shock response (HSR) have been widely used to characterize the in vitro function of platelets and have been shown to correlate with in vivo viability. These assays have been routinely performed using platelet-poor plasma (PPP) as the test sample diluent. Because of the increasing popularity of storing platelets in synthetic media, it is important to understand the effects of using these synthetic media as test diluents for ESC and HSR measurements. The objective of this study was to determine the effect of using platelet storage solutions vs. plasma for the in vitro testing of ESC and HSR.
Six laboratories participated in this study. Platelets were prepared by apheresis, the platelet-rich plasma (PRP) method, or derived from buffy-coats. Each platelet preparation was divided, half being stored in plasma and the other half in storage solution. ESC and HSR testing were performed in duplicate on days 1 and 5, using each of three diluents: autologous plasma; fresh-frozen plasma; or storage solution.
For both ESC and HSR, dilutions made in each of the three diluents yielded significantly different results. Dilutions made in storage solutions were more than 30% lower for ESC and HSR than those made in autologous plasma (P < 0.0001). Dilutions made in thawed fresh-frozen plasma were more than 16% lower for ESC and HSR than those made in liquid autologous plasma (P < 0.0005).
ESC and HSR test results are significantly affected by the test diluent. Platelets should be diluted in plasma (preferably autologous) for the in vitro testing of ESC and HSR, regardless of the media in which they are stored.
形状变化程度(ESC)和低渗休克反应(HSR)已被广泛用于表征血小板的体外功能,并已证明与体内活力相关。这些检测通常使用乏血小板血浆(PPP)作为测试样品稀释剂。由于在合成培养基中储存血小板越来越普遍,了解使用这些合成培养基作为ESC和HSR测量的测试稀释剂的效果很重要。本研究的目的是确定使用血小板储存溶液与血浆进行ESC和HSR体外测试的效果。
六个实验室参与了本研究。通过单采、富血小板血浆(PRP)法或从 Buffy 层制备血小板。每种血小板制剂均被分开,一半储存在血浆中,另一半储存在储存溶液中。在第1天和第5天,使用三种稀释剂中的每一种对ESC和HSR进行重复测试:自体血浆;新鲜冷冻血浆;或储存溶液。
对于ESC和HSR,在三种稀释剂中的每一种中进行的稀释均产生了显著不同的结果。与在自体血浆中进行的稀释相比,在储存溶液中进行的ESC和HSR稀释低30%以上(P < 0.0001)。与在液体自体血浆中进行的稀释相比,在解冻的新鲜冷冻血浆中进行的ESC和HSR稀释低16%以上(P < 0.0005)。
ESC和HSR测试结果受测试稀释剂的显著影响。无论血小板储存在何种培养基中,进行ESC和HSR体外测试时均应在血浆(最好是自体血浆)中进行稀释。